Published in J Neuropathol Exp Neurol on September 01, 1992
Pericyte deficiencies lead to aberrant tumor vascularizaton in the brain of the NG2 null mouse. Dev Biol (2010) 1.34
Toward a noncytotoxic glioblastoma therapy: blocking MCP-1 with the MTZ Regimen. Onco Targets Ther (2016) 0.77
Alcohol, tobacco and breast cancer--collaborative reanalysis of individual data from 53 epidemiological studies, including 58,515 women with breast cancer and 95,067 women without the disease. Br J Cancer (2002) 5.83
Pooled analysis of prospective cohort studies on height, weight, and breast cancer risk. Am J Epidemiol (2000) 4.83
Development of a multiple sclerosis functional composite as a clinical trial outcome measure. Brain (1999) 4.41
Targeting of Bcl-2 to the mitochondrial outer membrane by a COOH-terminal signal anchor sequence. J Biol Chem (1993) 3.21
Neuroblastoma x spinal cord (NSC) hybrid cell lines resemble developing motor neurons. Dev Dyn (1992) 3.14
Evidence of axonal damage in the early stages of multiple sclerosis and its relevance to disability. Arch Neurol (2001) 2.75
Copy number variations of chromosome 16p13.1 region associated with schizophrenia. Mol Psychiatry (2009) 2.29
Helicobacter pylori infection and blood groups. Am J Gastroenterol (1996) 2.20
Axonal metabolic recovery in multiple sclerosis patients treated with interferon beta-1b. J Neurol (2001) 1.91
Chemokine monocyte chemoattractant protein-1 is expressed by astrocytes after mechanical injury to the brain. J Immunol (1996) 1.84
Pro-regenerative properties of cytokine-activated astrocytes. J Neurochem (2004) 1.83
Cortical dysplasia: an immunocytochemical study of three patients. Neurology (1998) 1.83
A patient education program is cost-effective for preventing failure of endoscopic procedures in a gastroenterology department. Am J Gastroenterol (2001) 1.81
Matrix metalloproteinase-9/gelatinase B is required for process outgrowth by oligodendrocytes. J Neurosci (1999) 1.81
Inositol stereoisomers stabilize an oligomeric aggregate of Alzheimer amyloid beta peptide and inhibit abeta -induced toxicity. J Biol Chem (2000) 1.76
Factors associated with radiation exposure in patients with inflammatory bowel disease. Aliment Pharmacol Ther (2009) 1.72
Axonal damage correlates with disability in patients with relapsing-remitting multiple sclerosis. Results of a longitudinal magnetic resonance spectroscopy study. Brain (1998) 1.71
Accurate, noninvasive diagnosis of human brain tumors by using proton magnetic resonance spectroscopy. Nat Med (1996) 1.71
Brain-immune connection: immuno-regulatory properties of CNS-resident cells. Glia (2000) 1.70
Induction and intracellular regulation of tumor necrosis factor-related apoptosis-inducing ligand (TRAIL) mediated apotosis in human malignant glioma cells. Cancer Res (2001) 1.70
Imaging axonal damage of normal-appearing white matter in multiple sclerosis. Brain (1998) 1.68
Peripheral blood gamma-delta T cells lyse fresh human brain-derived oligodendrocytes. Ann Neurol (1991) 1.54
Multiple sclerosis: Fas signaling in oligodendrocyte cell death. J Exp Med (1996) 1.53
Interferon beta-1b decreases the migration of T lymphocytes in vitro: effects on matrix metalloproteinase-9. Ann Neurol (1996) 1.51
Intramedullary dermoid tumor diagnosed with the assistance of magnetic resonance imaging. Neurosurgery (1988) 1.51
Pleuropneumonia in pigs caused by Haemophilus parahaemolyticus. Aust Vet J (1974) 1.48
Study of the carbohydrate content of mucus glycoproteins from normal and diseased colons. Clin Sci (Lond) (1981) 1.46
Inhibition of growth of established human glioma cell lines by modulators of the protein kinase-C system. J Neurosurg (1990) 1.46
Neuroleukin: a lymphokine product of lectin-stimulated T cells. Science (1986) 1.44
The origin of brain metastases in patients with an undiagnosed primary tumour. Acta Neurochir (Wien) (2004) 1.44
Reactive astrogliosis in the neonatal mouse brain and its modulation by cytokines. J Neurosci (1994) 1.44
PK11195 binding to the peripheral benzodiazepine receptor as a marker of microglia activation in multiple sclerosis and experimental autoimmune encephalomyelitis. J Neurosci Res (1997) 1.43
Estimating fine particulates less than 2.5 microns in aerodynamic diameter (PM2.5) from airport visibility data in California. J Expo Anal Environ Epidemiol (1996) 1.42
Prospective serial analysis of interleukin-2 and soluble interleukin-2 receptor in relapsing-remitting multiple sclerosis. Neurology (1992) 1.42
Multiple sclerosis flares associated with recombinant granulocyte colony-stimulating factor. Neurology (2000) 1.42
Expanding the range of ZNF804A variants conferring risk of psychosis. Mol Psychiatry (2010) 1.41
Factors associated with prolonged Escherichia coli O157 infection in a school outbreak. Public Health (2013) 1.40
Intractable epilepsy after a functional hemispherectomy: important lessons from an unusual case. Case report. J Neurosurg (2001) 1.38
P2X7-like receptor activation in astrocytes increases chemokine monocyte chemoattractant protein-1 expression via mitogen-activated protein kinase. J Neurosci (2001) 1.38
Amyotrophic lateral sclerosis and life-sustaining therapy: patients' desires for information, participation in decision making, and life-sustaining therapy. Mayo Clin Proc (1991) 1.37
The identification of novel therapeutic targets for the treatment of malignant brain tumors. Cancer Lett (2000) 1.36
Glial cell influence on the human blood-brain barrier. Glia (2001) 1.36
Comparison of phenotypic and functional properties of immediately ex vivo and cultured human adult microglia. Glia (1996) 1.35
Isolation of multipotent neural precursors residing in the cortex of the adult human brain. Exp Neurol (2001) 1.32
Immunohistochemical and genetic evidence of myeloperoxidase involvement in multiple sclerosis. J Neuroimmunol (1997) 1.27
Gamma-interferon promotes proliferation of adult human astrocytes in vitro and reactive gliosis in the adult mouse brain in vivo. Proc Natl Acad Sci U S A (1991) 1.27
Hallervorden-Spatz disease: cysteine accumulation and cysteine dioxygenase deficiency in the globus pallidus. Ann Neurol (1985) 1.26
MHC class I-restricted lysis of human oligodendrocytes by myelin basic protein peptide-specific CD8 T lymphocytes. J Immunol (1998) 1.26
Cyclin-dependent kinase-5 prevents neuronal apoptosis through ERK-mediated upregulation of Bcl-2. Cell Death Differ (2005) 1.25
Proton magnetic resonance spectroscopic imaging for metabolic characterization of demyelinating plaques. Ann Neurol (1992) 1.24
Inhibition of terminal axonal sprouting by serum from patients with amyotrophic lateral sclerosis. N Engl J Med (1984) 1.23
Interleukin-1 is a key regulator of matrix metalloproteinase-9 expression in human neurons in culture and following mouse brain trauma in vivo. J Neurosci Res (2000) 1.21
Comparison between ventriculoatrial and ventriculoperitoneal shunting in the adult population. Br J Neurosurg (1997) 1.20
PTEN/MMAC1/TEP1 in signal transduction and tumorigenesis. Eur J Biochem (1999) 1.20
Regulation of Th1 and Th2 lymphocyte migration by human adult brain endothelial cells. J Neuropathol Exp Neurol (2001) 1.20
Strategy for anti-aquaporin-4 auto-antibody identification and quantification using a new cell-based assay. Clin Immunol (2010) 1.20
The second European evidenced-based consensus on reproduction and pregnancy in inflammatory bowel disease. J Crohns Colitis (2015) 1.19
Biology of adult human microglia in culture: comparisons with peripheral blood monocytes and astrocytes. J Neuropathol Exp Neurol (1992) 1.19
Periventricular and subcortical nodular heterotopia. A study of 33 patients. Brain (1995) 1.19
The clinical response to minocycline in multiple sclerosis is accompanied by beneficial immune changes: a pilot study. Mult Scler (2007) 1.18
Detection of cortical neuron loss in motor neuron disease by proton magnetic resonance spectroscopic imaging in vivo. Neurology (1994) 1.18
Expression of mRNA for the serotonin 5-hydroxytryptamine1D beta receptor subtype in human and bovine cerebral arteries. Mol Pharmacol (1993) 1.18
Central nervous system-initiated inflammation and neurotrophism in trauma: IL-1 beta is required for the production of ciliary neurotrophic factor. J Immunol (2000) 1.17
Suppressor cell function in multiple sclerosis: correlation with clinical disease activity. Ann Neurol (1979) 1.17
In vivo evidence for axonal dysfunction remote from focal cerebral demyelination of the type seen in multiple sclerosis. Brain (1999) 1.17
Overexpression of 2',3'-cyclic nucleotide 3'-phosphodiesterase in transgenic mice alters oligodendrocyte development and produces aberrant myelination. Mol Cell Neurosci (1996) 1.17
Idiopathic Parkinson's disease, progressive supranuclear palsy and glutathione metabolism in the substantia nigra of patients. Neurosci Lett (1986) 1.17
Inflammatory pseudotumors in children. J Pediatr Surg (1988) 1.17
Functional consequences of S1P receptor modulation in rat oligodendroglial lineage cells. Glia (2007) 1.16
Interleukin-1 beta is required for the early evolution of reactive astrogliosis following CNS lesion. J Neuropathol Exp Neurol (2001) 1.15
Microglial production of TNF-alpha is induced by activated T lymphocytes. Involvement of VLA-4 and inhibition by interferonbeta-1b. J Clin Invest (1997) 1.15
Screening for colorectal neoplasia: a multicenter study in Israel. Isr J Med Sci (1992) 1.15
Comparison of two bowel preparations for colonoscopy: sodium picosulphate with magnesium citrate versus sulphate-free polyethylene glycol lavage solution. Am J Gastroenterol (1998) 1.15
Imaging of axonal damage in multiple sclerosis: spatial distribution of magnetic resonance imaging lesions. Ann Neurol (1997) 1.15
A threonine to isoleucine missense mutation in the pericentriolar material 1 gene is strongly associated with schizophrenia. Mol Psychiatry (2008) 1.14
Circulating suppressor cells in man as a function of age. Clin Immunol Immunopathol (1978) 1.13
Mesial atrophy and outcome after amygdalohippocampectomy or temporal lobe removal. Ann Neurol (1996) 1.13
Involvement of p21(Waf1/Cip1) in protein kinase C alpha-induced cell cycle progression. Mol Cell Biol (2000) 1.13
Amyotrophic lateral sclerosis with antecedent poliomyelitis. Arch Neurol (1980) 1.13
Bilateral juxtapapillary subretinal neovascularization associated with pseudotumor cerebri. Am J Ophthalmol (1981) 1.12
Estimating unreported malaria cases in England: a capture-recapture study. Epidemiol Infect (2009) 1.12
Differential activation of ERKs to focal adhesions by PKC epsilon is required for PMA-induced adhesion and migration of human glioma cells. Oncogene (2001) 1.12
Regulation of CD14 expression on human adult central nervous system-derived microglia. J Neurosci Res (1996) 1.11
Umbravirus gene expression helps potato leafroll virus to invade mesophyll tissues and to be transmitted mechanically between plants. Virology (2001) 1.11
Changes in concanavalin A capping of human lymphocytes with age. Mech Ageing Dev (1980) 1.09
Inhibition of medulloblastoma cell invasion by Slit. Oncogene (2006) 1.09
A motile but non-swarming mutant of Proteus mirabilis lacks FlgN, a facilitator of flagella filament assembly. Mol Microbiol (1997) 1.08
Putting magnetic resonance spectroscopy studies in context: axonal damage and disability in multiple sclerosis. Semin Neurol (1998) 1.08
Efficiency and safety of bilateral contemporaneous pallidal stimulation (deep brain stimulation) in levodopa-responsive patients with Parkinson's disease with severe motor fluctuations: a 2-year follow-up review. J Neurosurg (1998) 1.06
Aquaporin 1 and aquaporin 4 expression in human brain after subarachnoid hemorrhage and in peritumoral tissue. Acta Neurochir Suppl (2003) 1.06
Chemical pathology of acute demyelinating lesions and its correlation with disability. Ann Neurol (1995) 1.04
HIV-1 Tat neurotoxicity is prevented by matrix metalloproteinase inhibitors. Ann Neurol (2001) 1.04
The value of interhospital transfer and emergency MRI for suspected cauda equina syndrome: a 2-year retrospective study. Ann R Coll Surg Engl (2008) 1.04
A human glial hybrid cell line differentially expressing genes subserving oligodendrocyte and astrocyte phenotype. J Neurobiol (1995) 1.04
B7/BB-1 antigen expression on adult human microglia studied in vitro and in situ. Eur J Immunol (1994) 1.03
Oligodendrocytes utilize a matrix metalloproteinase, MMP-9, to extend processes along an astrocyte extracellular matrix. Glia (1998) 1.03
Marked inhibition of tumor growth in a malignant glioma tumor model by a novel synthetic matrix metalloproteinase inhibitor AG3340. Clin Cancer Res (1999) 1.03